{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T04:54:08Z","timestamp":1767848048879,"version":"3.49.0"},"reference-count":18,"publisher":"Elsevier BV","issue":"43","license":[{"start":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T00:00:00Z","timestamp":1538352000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,9,18]],"date-time":"2018-09-18T00:00:00Z","timestamp":1537228800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"name":"Food and Drug Administration Intramural Research Program"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2018,10]]},"DOI":"10.1016\/j.vaccine.2018.09.012","type":"journal-article","created":{"date-parts":[[2018,9,16]],"date-time":"2018-09-16T02:26:46Z","timestamp":1537064806000},"page":"6379-6382","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"title":["Improving the stability of recombinant anthrax protective antigen vaccine"],"prefix":"10.1016","volume":"36","author":[{"given":"Anita","family":"Verma","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Drusilla L.","family":"Burns","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2018.09.012_b0005","doi-asserted-by":"crossref","first-page":"1512","DOI":"10.1128\/CVI.00469-14","article-title":"Comprehensive analysis and selection of anthrax vaccine adsorbed immune correlates of protection in rhesus macaques","volume":"21","author":"Chen","year":"2014","journal-title":"Clin Vaccine Immunol"},{"key":"10.1016\/j.vaccine.2018.09.012_b0010","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1128\/CVI.00099-13","article-title":"Evaluation of immunogenicity and efficacy of anthrax vaccine adsorbed for postexposure prophylaxis","volume":"20","author":"Ionin","year":"2013","journal-title":"Clin Vaccine Immunol"},{"key":"10.1016\/j.vaccine.2018.09.012_b0015","doi-asserted-by":"crossref","first-page":"4768","DOI":"10.1016\/S0264-410X(01)00234-1","article-title":"In vitro correlate of immunity in a rabbit model of inhalational anthrax","volume":"19","author":"Pitt","year":"2001","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2018.09.012_b0020","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1146\/annurev.cellbio.19.111301.140655","article-title":"Anthrax toxin","volume":"19","author":"Collier","year":"2003","journal-title":"Annu Rev Cell Dev Biol"},{"key":"10.1016\/j.vaccine.2018.09.012_b0025","doi-asserted-by":"crossref","first-page":"806","DOI":"10.4161\/hv.9777","article-title":"Is new always better than old?: The development of human vaccines for anthrax","volume":"5","author":"Baillie","year":"2009","journal-title":"Hum Vaccine"},{"key":"10.1016\/j.vaccine.2018.09.012_b0030","series-title":"Deamidation and isoaspartate formation in peptides and proteins","author":"Aswad","year":"1995"},{"key":"10.1016\/j.vaccine.2018.09.012_b0035","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1007\/s00018-003-2287-5","article-title":"Deamidation and isoaspartate formation in proteins: unwanted alterations or surreptitious signals?","volume":"60","author":"Reissner","year":"2003","journal-title":"Cell Mol Life Sci"},{"key":"10.1016\/j.vaccine.2018.09.012_b0040","doi-asserted-by":"crossref","first-page":"39897","DOI":"10.1074\/jbc.M508569200","article-title":"Effects of spontaneous deamidation on the cytotoxic activity of the Bacillus anthracis protective antigen","volume":"280","author":"Zomber","year":"2005","journal-title":"J Biol Chem"},{"key":"10.1016\/j.vaccine.2018.09.012_b0045","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1002\/prot.21432","article-title":"Multiple asparagine deamidation of Bacillus anthracis protective antigen causes charge isoforms whose complexity correlates with reduced biological activity","volume":"68","author":"Powell","year":"2007","journal-title":"Proteins"},{"key":"10.1016\/j.vaccine.2018.09.012_b0050","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1128\/IAI.00863-12","article-title":"Use of site-directed mutagenesis to model the effects of spontaneous deamidation on the immunogenicity of Bacillus anthracis protective antigen","volume":"81","author":"Verma","year":"2013","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2018.09.012_b0055","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1002\/jps.23422","article-title":"Rapid deamidation of recombinant protective antigen when adsorbed on aluminum hydroxide gel correlates with reduced potency of vaccine","volume":"102","author":"D'Souza","year":"2013","journal-title":"J Pharm Sci"},{"key":"10.1016\/j.vaccine.2018.09.012_b0060","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1128\/mBio.00209-18","article-title":"Role of the antigen capture pathway in the induction of a neutralizing antibody response to anthrax protective antigen","volume":"9","author":"Verma","year":"2018","journal-title":"mBio"},{"key":"10.1016\/j.vaccine.2018.09.012_b0065","doi-asserted-by":"crossref","first-page":"6367","DOI":"10.1073\/pnas.0401506101","article-title":"Crystal structure of the von Willebrand factor A domain of human capillary morphogenesis protein 2: an anthrax toxin receptor","volume":"101","author":"Lacy","year":"2004","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.vaccine.2018.09.012_b0070","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1128\/CVI.00174-12","article-title":"Structural and immunological analysis of anthrax recombinant protective antigen adsorbed to aluminum hydroxide adjuvant","volume":"19","author":"Wagner","year":"2012","journal-title":"Clin Vaccine Immunol"},{"key":"10.1016\/j.vaccine.2018.09.012_b0075","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1128\/CVI.00081-08","article-title":"Role of the N-terminal amino acid of Bacillus anthracis lethal factor in lethal toxin cytotoxicity and its effect on the lethal toxin neutralization assay","volume":"15","author":"Verma","year":"2008","journal-title":"Clin Vaccine Immunol"},{"key":"10.1016\/j.vaccine.2018.09.012_b0080","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1128\/CVI.00513-09","article-title":"Comparison of three anthrax toxin neutralization assays","volume":"17","author":"Ngundi","year":"2010","journal-title":"Clin Vaccine Immunol"},{"key":"10.1016\/j.vaccine.2018.09.012_b0085","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1111\/j.1399-3011.2004.00151.x","article-title":"Structure-dependent nonenzymatic deamidation of glutaminyl and asparaginyl pentapeptides","volume":"63","author":"Robinson","year":"2004","journal-title":"J Pept Res"},{"key":"10.1016\/j.vaccine.2018.09.012_b0090","doi-asserted-by":"crossref","first-page":"3107","DOI":"10.1167\/iovs.09-4308","article-title":"Age-dependent deamidation of lifelong proteins in the human lens","volume":"51","author":"Hains","year":"2010","journal-title":"Invest Ophthalmol Vis Sci"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X18312611?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X18312611?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,4]],"date-time":"2018-10-04T23:44:29Z","timestamp":1538696669000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X18312611"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10]]},"references-count":18,"journal-issue":{"issue":"43","published-print":{"date-parts":[[2018,10]]}},"alternative-id":["S0264410X18312611"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2018.09.012","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2018,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Improving the stability of recombinant anthrax protective antigen vaccine","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2018.09.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}